{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-117768","form_type":"8-K","ticker":"CYDY","cik":"0001175680","company_name":"CytoDyn Inc.","filed_at":"2022-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.944477+00:00","generated_at":"2026-06-26T04:57:58.443483+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"CytoDyn reorganizes management: Ray remains CTO, Recknor no longer executive officer","bullets":["Nitya G. Ray, Ph.D., no longer COO; continues as Chief Technology Officer.","Christopher P. Recknor, M.D., named Senior Director of R&D, ceases to be executive officer.","Board approved reorganization on April 19, 2022; effective immediately."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-117768","json":"https://secwatch.observer/filing/0001193125-22-117768.json","markdown":"https://secwatch.observer/filing/0001193125-22-117768.md","text":"https://secwatch.observer/filing/0001193125-22-117768.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175680/000119312522117768/0001193125-22-117768-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175680/000119312522117768/d341269d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T04:57:58.443483+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"20c9e79e8d","claim":"Nitya G. Ray changed role as Chief Operating Officer at CytoDyn Inc..","evidence_excerpt":"Nitya G. Ray, Ph.D., will continue in his role as Chief Technology Officer, but will no longer serve as Chief Operating Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1175680/000119312522117768/0001193125-22-117768-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will no longer serve as Chief Operating Officer"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"4fefb8d335","claim":"Christopher P. Recknor changed role as Senior Director of Research and Development at CytoDyn Inc..","evidence_excerpt":"Christopher P. Recknor, M.D., will serve as Senior Director of Research and Development, but will no longer be an executive officer of the Company as defined in the rules of the Securities and Exchange Commission.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1175680/000119312522117768/0001193125-22-117768-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will serve as Senior Director of Research and Development, but will no longer be an executive officer"},{"label":"Role","value":"Senior Director of Research and Development"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}